AD diagnosis has still faced challenges due to the complex environment in vivo and the interaction of Aβ with other biomolecules (such as Tau protein) though the sensitive sensing of Aβ based on aptamers has been achieved successfully. This evidence concerns the gene MAPT and Alzheimer disease.